Diabetic foot is the most common cause of diabetes-related hospitalizations leading to more than 60% of nontraumatic lower limb amputations. In the last decades, the improvements in medical, surgical, and endovascular treatments and techniques have decreased the amputation rate in USA and Western Europe, but additional efforts are needed to further reduce the risk of limb loss. Moreover, diabetic foot problems also produce heavy socioeconomic implications, both direct and indirect, due to the loss of productivity, disability, and premature mortality. To date, there is strong evidence that multidisciplinary approach (i.e., diabetologist, vascular surgeon, podiatrist, etc.) is of paramount benefit in treating ischemic diabetic foot patients through patient selection and early intervention.

We invite investigators to submit original papers and review articles regarding all different aspects (clinical, experimental, surgical, interventional, etc.) of ischemic diabetic foot. Potential topics include, but are not limited to:

• Diabetic foot clinic and formation of multidisciplinary diabetic care team
• Prevention and management of diabetic foot ulcers
• Diagnostic evaluation and therapeutic indications
• Medical therapy
• Surgical therapy
• Endovascular therapy
• New perspectives in gene and stem cell therapy

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/ijvm/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/ijvm/idf/ according to the following timetable: